skip to main content

Cisatracurium vs Atracurium — FRCA Primary MCQ

Instant feedback + full explanation. One question, done properly.

HardPharmacology - NeuromuscularCisatracurium vs AtracuriumFRCA Primary

Which property distinguishes cisatracurium from atracurium at usual clinical doses?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: CMinimal dose-dependent histamine release with Hofmann elimination

The best answer is “Minimal dose-dependent histamine release with Hofmann elimination”. Cisatracurium undergoes Hofmann elimination and clinical studies found no dose-dependent histamine release even at high multiples of ED95. Atracurium has more histamine-release potential. Cisatracurium is a non-depolarising blocker and is not dependent on hepatic CYP metabolism or plasma cholinesterase.

Reference: Cisatracurium 2 mg/mL, Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/1380/smpc